Device
Demineralized Bone Matrix
Demineralized Bone Matrix is a medical device with 5 clinical trials. Currently 1 active trials ongoing. Historical success rate of 50.0%.
Total Trials
5
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
50.0%
Based on 1 completed trials
Completion Rate
50%(1/2)
Active Trials
1(20%)
Results Posted
200%(2 trials)
Terminated
1(20%)
Phase Distribution
Ph not_applicable
4
80%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
33.3%
1 of 3 finished
Non-Completion Rate
66.7%
2 ended early
Currently Active
1
trials recruiting
Total Trials
5
all time
Status Distribution
Active(1)
Completed(1)
Terminated(2)
Other(1)
Detailed Status
Completed1
Recruiting1
Withdrawn1
unknown1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
1
Success Rate
50.0%
Most Advanced
N/A
Trials by Phase
N/A4 (100.0%)
Trials by Status
completed120%
recruiting120%
withdrawn120%
unknown120%
terminated120%
Recent Activity
1 active trials
Showing 5 of 5
recruitingnot_applicable
FIBERGRAFT Aeridyan Posterolateral Fusion Study
NCT07059065
withdrawn
A Study Evaluating 3-Level OLIF Spine Fusion
NCT03896347
unknownnot_applicable
Demineralized Bone Matrix Rotator Cuff Study
NCT04686396
terminatednot_applicable
Human Amniotic Tissue-derived Allograft, NuCel, in Posteriolateral Lumbar Fusions for Degenerative Disc Disease
NCT02070484
completednot_applicable
Efficacy and Safety of Accell Evo3 Demineralized Bone Matrix (DBM) in Instrumented Posterolateral Lumbar Spine Fusion
NCT01430299
Clinical Trials (5)
Showing 5 of 5 trials
NCT07059065Not Applicable
FIBERGRAFT Aeridyan Posterolateral Fusion Study
NCT03896347
A Study Evaluating 3-Level OLIF Spine Fusion
NCT04686396Not Applicable
Demineralized Bone Matrix Rotator Cuff Study
NCT02070484Not Applicable
Human Amniotic Tissue-derived Allograft, NuCel, in Posteriolateral Lumbar Fusions for Degenerative Disc Disease
NCT01430299Not Applicable
Efficacy and Safety of Accell Evo3 Demineralized Bone Matrix (DBM) in Instrumented Posterolateral Lumbar Spine Fusion
All 5 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 5